跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STREPSILS CHESTY COUGH LOZENGE - HSA Drug Approval Details
Approvals
/
HSA
/
STREPSILS CHESTY COUGH LOZENGE
Approved
THERAPEUTIC
STREPSILS CHESTY COUGH LOZENGE
RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD
🇸🇬 Health Sciences Authority
Approval Date
Nov 15, 2001
Approval ID
2b29f3c533e3da80
Company
RECKITT BENCKISER HEALTHCARE MANUFACTURING (THAILAND) LTD
Type
Therapeutic
Approval Details
Approval Id
2b29f3c533e3da80
Drug Name
STREPSILS CHESTY COUGH LOZENGE
Product Name
STREPSILS CHESTY COUGH LOZENGE
Approval Number
SIN11716P
Approval Date
2001-11-15
Registrant
RECKITT BENCKISER (SINGAPORE) PTE LTD
Licence Holder
RECKITT BENCKISER (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
LOZENGE
Route Of Administration
ORAL
Atc Code
R05CB06
Atc Item Name
ambroxol
Pharma Manufacturer Name
RECKITT BENCKISER (SINGAPORE) PTE LTD
Company Detail Path
/organization/reckitt-benckiser-singapore-pte-ltd
Active Ingredients
AMBROXOL HCl
15 mg
AMBROXOL HCL
15 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 15, 2001
Approval ID
2b29f3c533e3da80
Type
Therapeutic
Back to HSA Approvals